Fidari

The most expensive part of cancer care is the part nobody bills for

Here is a fact that sounds like a paradox but isn't. In oncology, the thing that most often sends a patient to the emergency room is not the tumor. It's the appointment that never got scheduled, the ride that fell through, the nausea that went unreported for four days because nobody was watching. Cancer care is delivered in fifteen-minute clinic visits, but cancer is lived in the weeks between them. That gap - unglamorous, unphotographed, and until recently un-reimbursed - is the entire business of Fidari.

Fidari, founded in 2023 and headquartered in Santa Fe, New Mexico, describes what it does in refreshingly un-startup language: "creating the infrastructure for navigation in oncology." Navigation, in cancer-care jargon, means the human work of steering a patient through the maze - booking the scan, chasing the referral, flagging the symptom, connecting the person to a nutritionist or a therapist or a ride. Almost every hospital promises its cancer patients a navigator. Very few can tell you, on any given Tuesday, what that navigator actually did. The work is real, it is clinical, and it mostly happens in spreadsheets, sticky notes, and the memory of overworked nurses.

Fidari's insight is less a technology than an accounting one. The company built software that plugs into a hospital's existing electronic health record through the FHIR and HL7 standards - the boring pipes of healthcare data - and makes navigation legible. It automates the workflows, assigns the tasks, standardizes the care pathways, and, crucially, captures the documentation that lets a practice bill for navigation services it was already performing for free. The pitch to a community oncology practice is almost suspiciously simple: keep your system, keep your team, and stop leaving money on the table. Fidari says implementation takes four to six weeks, which in enterprise healthcare is roughly the speed of light.

This matters because the graveyard of health-tech startups is filled with companies that asked hospitals to rip out what they had and adopt something new. Clinicians hate new systems the way cats hate baths. Fidari's decision to be additive rather than disruptive - to sit inside the EHR rather than replace it - is the kind of unsexy strategic choice that tends to correlate with survival.

Five things, one layer

Strip away the language and Fidari is doing several distinct jobs stacked on top of one navigation layer. It automates the coordination work. It captures the revenue that work generates. It runs a marketplace that connects patients to supportive services - mental health, exercise, diet and nutrition counseling - either inside their insurance network or through a virtual bench of providers. It layers AI and machine learning on top to help navigators triage symptoms and figure out the right site of care. And, quietly, it turns all of that structured activity into de-identified real-world data that life-sciences companies will pay for.

A three-sided market where the incentives (mostly) agree

Fidari's most interesting feature is structural. Pharmaceutical companies will pay for de-identified real-world data. Patients need supportive care that is free at the point of use. Providers are drowning in navigation work they can't bill for. These are usually three separate businesses with three separate sales motions. Fidari's bet is that one navigation layer can serve all three at once - patients, providers, and payers/pharma - with the same underlying data doing multiple jobs.

It's a marketplace where a patient's connection to a nutritionist also becomes a documented, billable navigation event and a data point in an outcomes study. Whether that alignment holds at scale is the open question every three-sided market eventually faces. But the ambition is coherent: in healthcare, the integrator who connects the fragments often beats the innovator who builds a shinier fragment.

Who else is in the maze

Fidari is not alone in oncology navigation and digital care coordination. It shares the field with companies like Navigating Care, careMESH, Thyme Care, Jasper Health, Guideway Care, and Carevive, among other patient-navigation and real-world-data platforms. Fidari's differentiator is its insistence on being EHR-native and revenue-capturing rather than a standalone app - meeting oncology practices inside the systems they already run.